GCI Earnings

GCI reported its FY2025Q3 earnings on 2025-10-30, showcasing a revenue of 561.00M against an estimate of 571.00M, resulting in a -1.79% surprise. The EPS was -0.21, surpassing the expected -0.12 by -75% . The stock experienced a 27.74% price change on the earnings day and a 23.84% change over the next five days, reflecting market reactions to the results.

Following GCI's FY2025Q3 earnings announcement on 2025-10-30, the stock price moved by 27.74% on the day of the release. Over the subsequent five days, it saw a 23.84% change. Historically, GCI's stock price tends to shift by an average of -4.83% in the 10 days leading up to earnings and +4.21% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate GCI’s annual revenue to reach 591.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.05% and EPS estimates Revise Upward by 0.04% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between GCI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.05%, while EPS estimates moved Revise Upward by 0.04% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, GCI's stock price typically moves by -4.83% in the 10 days before its earnings and +4.21% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 591.00M.

The earnings call presents a mixed picture: positive elements include a favorable ruling in the Google antitrust case, debt reduction, and strong digital advertising growth. However, digital revenue declined, and there's uncertainty around AI partnerships and OpenAI negotiations. The shift of revenue drivers to Q4 and incremental expenses from the cost reduction program further complicate the outlook. With no clear market cap, the impact remains uncertain, but the balance of positives and negatives suggests a neutral stock price movement.